Genetic Testing
Laboratory analysis of DNA, RNA, chromosomes, or proteins to detect inherited conditions, disease risk, carrier status, or pharmacogenomic factors. Results guide diagnosis, treatment selection, and screening, and coverage and prior authorization rules vary significantly across payers.
What is genetic testing?
Genetic testing is laboratory analysis of DNA, RNA, chromosomes, or proteins to detect inherited conditions, assess disease risk, identify carrier status, or inform medication selection. It can confirm a suspected diagnosis, guide screening decisions, or reveal how a patient may respond to certain drugs through pharmacogenomics.
Tests range from single-gene analyses to broad panels and may be ordered in many clinical contexts, from prenatal care to oncology. Results often influence both immediate treatment choices and longer-term monitoring.
Why does genetic testing matter for coverage and the revenue cycle?
Genetic testing increasingly shapes diagnosis and treatment, but payer coverage policies, medical-necessity criteria, and prior authorization rules differ widely across plans and tests. These variations make benefit verification and documentation especially important to avoid denials.
For the revenue cycle, the high cost and inconsistent coverage of some genetic tests put a premium on confirming authorization and coding correctly before testing proceeds. Careful front-end work reduces the financial risk to both patients and providers.
- what is genetic testing
- genetic testing meaning
- dna testing definition
- genetic test types
- genetic testing coverage
- pharmacogenomic testing